Corvus Pharmaceuticals CRVS Q1 2026 Earnings RD Pipeline Progress Amid Slight EPS Miss ARE Q1 2026 Earnings Earnings Per Share Soars 1459 Above Estimates Stock Slips Modestly RILYP Q1 2024 Earnings Preferred Stock Reports Negative EPS Amid No Revenue Estimate INDV Q1 2026 Earnings Strong EPS Beat Underscores Operational Discipline Neuropace NPCE Q1 2026 Earnings EPS Beat Surprises Market Stock Gains GOOGL Q1 2026 Earnings EPS Miss Amidst AI Investment Pressures